Future Financial Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Future Financial Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100	Closed	-$39.2K	–	429
2025 Q3	$39.2K	Hold	100	–	–	0.02%	280
2025 Q2	$44.5K	Hold	100	–	–	0.03%	260
2025 Q1	$48.5K	Hold	100	–	–	0.04%	242
2024 Q4	$40.3K	Hold	100	–	–	0.03%	263
2024 Q3	$46.5K	Buy	+100	New	+$48K	0.03%	262
2024 Q2	–	Sell	-100	Closed	-$41.8K	–	464
2024 Q1	$41.8K	Buy	+100	New	+$42.3K	0.03%	281

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Future Financial Wealth Management's VRTX Position: Q4 2025 in Review

Future Financial Wealth Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 100 shares — an estimated $39.2K sold.

Future Financial Wealth Management first reported a position in VRTX in Q1 2024 and held it in 6 quarters. The position peaked at $48.5K in Q1 2025. 1,670 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

Future Financial Wealth Management reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Future Financial Wealth Management sold 100 Vertex Pharmaceuticals shares in Q4 2025, an estimated $39.2K.
Future Financial Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2024 and held it in 6 quarters.
Future Financial Wealth Management's Vertex Pharmaceuticals position peaked at $48.5K in Q1 2025.
1,670 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Future Financial Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.